Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)

Market Cap	4.67B -16.9%
Revenue (ttm)	1.08B +2.4%
Net Income	163.02M -44.1%
EPS	0.38 -43.9%
Shares Out	428.49M
PE Ratio	28.50
Forward PE	19.62
Dividend	0.28 (2.56%)
Ex-Dividend Date	May 28, 2026

Volume	1,232,023
Open	10.76
Previous Close	10.89
Day's Range	10.65 - 10.89
52-Week Range	10.65 - 14.88
Beta	0.42
Analysts	Strong Buy
Price Target	14.68 (+36.56%)
Earnings Date	Aug 28, 2026

About SHA:688389

Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products. In addition, the company provides medical and aesthetic, and laser hair removal products, as well...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,756
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688389

Financial Performance

In 2025, SHA:688389's revenue was 1.04 billion, a decrease of -9.60% compared to the previous year's 1.15 billion. Earnings were 184.22 million, a decrease of -46.66%.

Analyst Summary

According to 3 analysts, the average rating for 688389 stock is "Strong Buy." The 12-month stock price target is ¥14.68, which is an increase of 36.56% from the latest price.

Price Target

¥14.68

(36.56% upside)

Analyst Consensus: Strong Buy